In in vivo tumour growth assays, the increase in both tumour volume and weight were detected in the group of mice injected with PRMT3‐overexpressing cells, whilst SGC707 treatment reversed this effect (Figure 7J–L). Here, PRMT3 is linked to neoplasm.